SEC Form 4 · accession 0001583810-19-000005
CALADRIUS BIOSCIENCES, INC. · CLBS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Douglas W Losordo
Officer — See Remarks
Period of report
Jan 8, 2019
Accepted (ET)
Jan 10, 2019 · 12:36 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000320017
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jan 8, 2019 | F | 1,795 | $4.64 | D | 97,753 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Includes 39,438 shares of unvested restricted stock.
Remarks
Executive Vice President, Global Head of Research and Development and Chief Medical Officer